Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Description

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Conditions

Prostate Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Observational and Prospective Study on the Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy (GenBx)

Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Evanston

NorthShore University HealthSystem, Evanston, Illinois, United States, 60626

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Consecutive patients undergoing prostate biopsy for detection of prostate cancer
  • * Aged 40 to 69 years
  • * Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
  • * PSA between 2.5-10 ng/mL
  • * Previous diagnosis of prostate cancer.
  • * Ethnicity outside the inclusion criterion (including mixed ethnicity).
  • * Any prior PSA test result outside the range of inclusion criterion.

Ages Eligible for Study

40 Years to 69 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

NorthShore University HealthSystem,

Jianfeng Xu, MD, Dr.PH, PRINCIPAL_INVESTIGATOR, NorthShore University HealthSystem

Study Record Dates

2025-12-13